Mildred Opondo, M.D
NPI 1609189463 · Cardiovascular Disease Physician · Hays, KS
Provider details
- NPI number
- 1609189463
- Entity type
- Individual
- Primary specialty
- Cardiovascular Disease PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D
- Sex
- Female
- Sole proprietor
- No
- License
- 92357 (GA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
15 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
419 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 161 | $117 |
| Routine Electrocardiogram (ecg) Using at Least 12 Leads With Interpretation and Report93000 | 72 | $13 |
| Evaluation of Implantable Heart and Blood Vessel Monitoring System93290 | 50 | $40 |
| Programming of Dual Lead Pacemaker System93280 | 48 | $70 |
| Initial Hospital Care With Straightforward Or Low-Level Medical Decision Making, If Using Time, at Least 55 Minutes99222 | 24 | $122 |
| Programming of Multiple Lead Implantable Defibrillator System93284 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 17 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Metoprolol Succinate | 90 | 30 |
| Sotalol Hclbrand: Sotalol | 54 | 19 |
| Apixabanbrand: Eliquis | 54 | 17 |
| Rivaroxabanbrand: Xarelto | 38 | — |
| Carvedilol | 38 | 14 |
| Spironolactone | 36 | 11 |
| Amiodarone Hcl | 35 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$322 across 5 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2010-07-22
- Last updated
- 2024-12-31
- Certified
- 2024-12-20
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.